ImmunityBio (IBRX) Asset Utilization Ratio (2015 - 2026)
ImmunityBio's (IBRX) Asset Utilization Ratio came in at 0.26 for Q2 2026, up 62.1% from 0.16 a year earlier and up 5.9% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
Since Q3 2015, ImmunityBio has reported Asset Utilization Ratio for 44 quarters.
- In prior years, ImmunityBio's Asset Utilization Ratio was 0.03 in FY2024, 0.00 in FY2023 (+148.5%), 0.00 in FY2022 (-78.7%) and 0.00 in FY2021 (-18.5%).
- The Q2 2026 figure stands as the highest quarterly Asset Utilization Ratio in data going back to Q3 2015.
- On a year-over-year basis, Asset Utilization Ratio has increased in each of the last four quarters, with growth averaging 395.9% over the last four quarters.
- The strongest year-over-year quarter for Asset Utilization Ratio in the past five years was Q3 2025, with growth of 888.8%; the weakest was Q4 2022, with a decline of 75.5%.
- According to Business Quant data, Asset Utilization Ratio for the three prior quarters was 0.25 (Q1 2026), 0.22 (Q4 2025) and 0.18 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 0.47 |
| 10 | ImmunityBio | 8.97 Bn | 7.74 Bn | 50.94 Mn | 0.26 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.26 |
| Mar 31, 2026 | 0.25 |
| Dec 31, 2025 | 0.22 |
| Sep 30, 2025 | 0.18 |
| Jun 30, 2025 | 0.16 |
| Mar 31, 2025 | 0.09 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
API Access
ImmunityBio Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();